0001104659-21-127870.txt : 20211020 0001104659-21-127870.hdr.sgml : 20211020 20211020074103 ACCESSION NUMBER: 0001104659-21-127870 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20211020 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20211020 DATE AS OF CHANGE: 20211020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Option Care Health, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 050489664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11993 FILM NUMBER: 211332739 BUSINESS ADDRESS: STREET 1: 3000 LAKESIDE DR STREET 2: SUITE 300N CITY: BANNOCKBURN STATE: IL ZIP: 60015 BUSINESS PHONE: 312 940 2443 MAIL ADDRESS: STREET 1: 3000 LAKESIDE DR STREET 2: SUITE 300N CITY: BANNOCKBURN STATE: IL ZIP: 60015 FORMER COMPANY: FORMER CONFORMED NAME: BioScrip, Inc. DATE OF NAME CHANGE: 20050314 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 8-K 1 tm2130572d1_8k.htm FORM 8-K
0001014739 false 0001014739 2021-10-20 2021-10-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

Form 8-K

 

 

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) 
of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 20, 2021

 

 

 

 

 

OPTION CARE HEALTH, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-11993 05-0489664

(Commission File Number)

(IRS Employer Identification No.)

 

3000 Lakeside Dr. Suite 300N, Bannockburn, IL 60015
(Address of Principal Executive Offices)  (Zip Code)

 

(312) 940-2443

(Registrant's Telephone Number, Including Area Code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange
on which registered
Common Stock, $0.0001 par value per share   OPCH   Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 2.02Results of Operations and Financial Condition.

 

On October 20, 2021, Option Care Health, Inc. issued a press release announcing its preliminary financial results for the three months ended September 30, 2021. A copy of the press release is furnished with this Form 8-K (this “Report”) and attached hereto as Exhibit 99.1.

 

The press release includes certain non-GAAP financial measures described therein. Reconciliation between any non-GAAP financial measures presented and the most directly comparable GAAP financial measures is also provided.

 

The information in this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01.Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description of Exhibits
99.1   Press Release, dated October 20, 2021.
104   The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Option Care Health, Inc.
     
Date: October 20, 2021 By:

/s/ Michael Shapiro

  Name: Michael Shapiro
  Title: Chief Financial Officer

 

 

EX-99.1 2 tm2130572d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 AND SCHEDULES THIRD QUARTER EARNINGS CALL

 

BANNOCKBURN, Ill., October 20, 2021 -- Option Care Health, Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”), the nation’s largest independent provider of home and alternate site infusion services, announced today its preliminary financial results for the third quarter ended September 30, 2021.

 

For the third quarter, Option Care Health expects to report:

 

·Net revenue of approximately $888 million to $893 million, representing approximately 14% growth over the prior year third quarter

 

·Net income of approximately $33 million to $36 million

 

·Adjusted EBITDA of approximately $76 million to $79 million, representing approximately a 28% to 34% increase over the prior year third quarter

 

·Cash flow from operations of approximately $50 million to $52 million

 

·Ending cash balance of approximately $200 million at September 30, 2021

 

Conference Call

 

The Company will release its third quarter results in their entirety on Thursday, November 4, 2021 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

 

The conference call can be accessed by dialing (866) 360-3136 and referencing conference ID 2812558; or via a live audio webcast that will be available online at https://investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

 

About Option Care Health

 

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 5,000 teammates, we work compassionately to elevate standards of care for patients with acute and chronic conditions in 144 locations around the United States. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates.

 

Forward-Looking Statements – Safe Harbor

 

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial condition.

 

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.

 

 

 

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings; (iii) results of litigation; (iv) the loss of one or more key payers; and (v) the spread and impact of the COVID-19 pandemic. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.

 

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

Preliminary Financial Data

 

The preliminary financial information included in this Report and the press release is subject to completion of the Company’s quarter-end close procedures and further financial review. The Company has provided ranges, rather than specific amounts, because these results are preliminary and subject to change. Actual results may differ from these estimates as a result of the completion of our quarter-end closing procedures, review adjustments and other developments that may arise between now and the time such financial information for the period is finalized. As a result, these estimates are preliminary, may change and constitute forward-looking information and, as a result, are subject to risks and uncertainties. These preliminary estimates should not be viewed as a substitute for full financial statements prepared in accordance with United States generally accepted accounting principles (“GAAP”), and they should not be viewed as indicative of our results for any future period. The Company’s independent registered public accountants have not audited, reviewed, compiled, or performed any procedures with respect to these estimated financial results and, accordingly, do not express an opinion or any other form of assurance with respect to these preliminary estimates.

 

Note Regarding Use of Non-GAAP Financial Measures

 

In addition to reporting financial information in accordance with GAAP, the Company is also reporting Adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is not a measurement of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, operating income or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of our liquidity. In addition, the Company’s definition of Adjusted EBITDA may not be comparable to similarly titled non-GAAP financial measures reported by other companies. Adjusted EBITDA, as defined by the Company, represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, and restructuring, acquisition, integration and other expenses. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long-lived assets, temporary redundant expenses, professional fees, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that Adjusted EBITDA provides useful supplemental information regarding the performance of our business operations and facilitates comparisons to our historical operating results. For a full reconciliation of Adjusted EBITDA to the most comparable GAAP financial measure, please see the following table.

 

2

 

 

OPTION CARE HEALTH, INC. 

RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES 

(IN MILLIONS) 

(UNAUDITED)

 

  

Three Months Ended

September 30, 2021

 
   Low   High 
Consolidated net income   $33.0   $36.0 
Interest expense, net    16.0    16.0 
Income tax expense    3.1    3.1 
Depreciation and amortization expense    17.1    17.1 
EBITDA    69.2    72.2 
Stock-based incentive compensation    2.5    2.5 
Restructuring, acquisition, integration and other    4.3    4.3 
Adjusted EBITDA   $76.0   $79.0 

 

For Investor Inquiries

 

Mike Shapiro, Chief Financial Officer 

Option Care Health 

312.940.2538 

Investor.relations@optioncare.com

 

3

 

EX-101.SCH 3 opch-20211020.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 opch-20211020_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 opch-20211020_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2130572d1_8kimg001.jpg GRAPHIC begin 644 tm2130572d1_8kimg001.jpg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tm2130572d1_ex99-1img001.jpg GRAPHIC begin 644 tm2130572d1_ex99-1img001.jpg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tm2130572d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001014739 2021-10-20 2021-10-20 iso4217:USD shares iso4217:USD shares 0001014739 false 8-K 2021-10-20 OPTION CARE HEALTH, INC. DE 001-11993 05-0489664 3000 Lakeside Dr. Suite 300N Bannockburn IL 60015 312 940-2443 false false false false Common Stock, $0.0001 par value per share OPCH NASDAQ false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover
Oct. 20, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 20, 2021
Entity File Number 001-11993
Entity Registrant Name OPTION CARE HEALTH, INC.
Entity Central Index Key 0001014739
Entity Tax Identification Number 05-0489664
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 3000 Lakeside Dr. Suite 300N
Entity Address, City or Town Bannockburn
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60015
City Area Code 312
Local Phone Number 940-2443
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol OPCH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://bioscrip.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2130572d1_8k.htm opch-20211020.xsd opch-20211020_lab.xml opch-20211020_pre.xml tm2130572d1_ex99-1.htm tm2130572d1_8kimg001.jpg http://xbrl.sec.gov/dei/2020-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2130572d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2130572d1_8k.htm" ] }, "labelLink": { "local": [ "opch-20211020_lab.xml" ] }, "presentationLink": { "local": [ "opch-20211020_pre.xml" ] }, "schema": { "local": [ "opch-20211020.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "OPCH", "nsuri": "http://bioscrip.com/20211020", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2130572d1_8k.htm", "contextRef": "From2021-10-20to2021-10-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://bioscrip.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2130572d1_8k.htm", "contextRef": "From2021-10-20to2021-10-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 16 0001104659-21-127870-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-127870-xbrl.zip M4$L#!!0 ( "$]5%/5\\R+0P, )(, 1 ;W!C:"TR,#(Q,3 R,"YX MY(ZT@U7'<\'I>X>$-C(5]4 M"8MP-\&^1CI6,[7RI)S]=J-?4X5GY!-T>3K^-.G1IR'AG^,NJC[C'ZA_'0]N M_=_/O9/*SY>)#K^<#/KL]7XZ?HWB6$XIKP5!+7P@PTYZ9%/A$0D1,"^#JY9C M\\O2&U=+0@[=2KGLN4_7W7Z"_5ZW4UV<^@:NNG9[ M@!29*9M=N@5/N=*(XR6\KV>$1?"IFVXN06DAM)9":0[UR0I.$5P:BC?7;!A\ MI0S+'JQZ.3Q6<(A0-*,$2 T2Z6RC@**D7H>;8#$4ZFE$5"$AW2J@W=ZUO\\8 M RH4EC2RM6JQGF?PIN,8"0G75T*&7TF 8F9,O<:(T8 2WP$:R2'1MOA4A##Y MBUI>P8AS80K==%L6L;$HHJ:23>!=T[[RAA2,W!OGP"Y,BQ5KVTVW+LD#T'9.;!,SRX32=%?!"Q*Q(OXM/T_6D23*\!+W M71/(B!ED PDCAF.V'V=NI9"2!?);FM];WB\]$H"DSQKV_;<<1>VD<[+82)*@ MY8@(CV#^>GZ9U$JF,G*(E=[29\G-K]Y&=G N@21>4UF; T9$1$1J:HITH=E3 MZU1;^MW",<">HQS@_HN4&1KLF[*A$/8?<^U:_<4DLP9QYQV2/:]V4=.D*Z0& M?*T=MTW)=+YW!4ZDME#L$\QYT(:@5S'CI#11_MSI/B;F-["?B9QW@(FML[K( MA=I$L@LX9^]J8.ODWW -R?F%1)!GZ87[6KI6R.6" M0V[&M:1XMU)99-ZD1%LK=5LK7NU(,X<9.=C%4O%A$7,MI_M7[2(Q?SBF7E8_ M1'8JE9R4EHG]-#G.P:$EN^YC<[TVW532+/\ 4$L#!!0 ( "$]5%-,FA=^ M 0L .*' 5 ;W!C:"TR,#(Q,3 R,%]L86(N>&ULS9U=;^.X%8;O"_0_ ML-Z;%AC'<8(MD.S,+C*>9&%L-DECSVS;1;&@)<810I,!)2?VOR\IB;)$\4A* MBI+,148COH=Z*3XAJ0]2'W_:;2AZ(2)-./LTFAX=CQ!A$8\3MOXT^KH87RQF M\_D(I1EF,::_A50HE ,[YYIB0C,J$X\#GZ_FAZC-%X/"#?;X3%7'R] MGU?Y/F;9:L*=S M]6N%4X+D^6+I^2Y-/HW4<<;&>G!P?3R?__/5Z$3V2#1XG3)VWB(QT ME,K%%C<].SN;Y*E:VE+N5H+J8YQ.M)TJ9YF:=.AK3M+D/,WM7?,(9WFU]QX& M@0KUO[&6C=6N\?1D?#H]VJ7Q2)_\_ P*3LD]>4!Y,<^S_;-$*4T4":-RWZ,@ M#W8S5(B)BI\PLL89B=6!SM2!IG]7!_JNW'V-5X2.D%)*/L!RG37R*H,FKLW> M$9'P^)*]S[49[8;IN\S7(YW;OB'O.^.'./=G6K;S MY'UGNA;Y?[&=M2V_^?3:SRM5.Z_E5L,BV66R R.Q-JFRZ&B!\R/D'4.9=Y4[ MCQKY4M6:<]$NN^H9\SQ3$AVM^6%^32RI$],8TIY(;0[+**>(I:*2<1E!_6>6Q#_HJHHO3HX\!&"T(1,DY5L1D3?53=TM=)9*1QLJ%6I@1=CXZV+T8ZY! MOVO5?SY.#KDXJVXY'-IN",N6,E]+.9K)KBK;9DK7=3TMB*JV&#)K6DN0TGBI MY@MY^%A9N*)X;2F$D>ZJHJVV=$TW$H.H:ILCLZXK#5(BOY7]A:212)[5,+^K M- V9\ZJWF&P14-.$!4+;&,Q#3>NUJ;\GZT1U.A*HHKS1=,+;%])X\<]$%45/FFAV;21.9NB8H4BS&0$ * M+2K$7KGXQU9>VQ-!][UHM)2NZ0"LFH 8LJ 8L7L#,:GD(9"R%)BEB6K2>E%I M2YU?D@!F6Y2DT>@,B0T>"Y?U A>#J(&%KFF]XE0RW87194X6)!,AP-9RL.0BO/*4^U! M1@])+:5KA@"K)CV&+"AN[-Y 8@HYRO6AH'+)XD&@5#H_F!@V[9"4H@ 1:3KK M T2J_>-QE:01IH6C*[DO[2BD1>L:$]"NB4I+&!0ND#L0F2) DY.'!(#-OP@6 MPZ"I*?T@T[)J!Z:2!8B+Z:T/%J7WB,IL*T3#.]P'P5)G#WI[S%;/? %=$+CT MF&L]"2[D#5R\]DF7+$NRO7I?[V:[61%A*6);XHH0R)PFPTP/@@C E$E"(4-* MAPJAQ_K73QM8IEZ5! MERMQR8#?99*&I"8@'JS& B8,V?W/5(Q\;@3R0:+_2*)>CJ/MM M M()#1)B&F*B!$ &L (Z4:+>8S_WW+$N_FL80V>4B*]]![6 'U;I'IL=TD!Q ' M!%"W0X C&82:4?YQFK.(BV=>>YUBQK>R2=S/> R/7'JBW*(UJ A-P#I# L)L MB$\ MD;HA^*=%\35+*(\ Z1R\,C=11S+TY66_UPGC$S!LV#5NF6LPVZ3+(LP M()Y@=P!%I?*#WD J!MVRL- Y>4.!3_RCBB5_M;T:#BJ]@-.V:L7F( L/FI:W/F14 M@!KGJ!#_L.3#KEMQ)_A+PB)X0 W)O6 #F+:R8VC# \ANL(^B:KBLX_RC5 [< M>_]@M,Q/B],T:6]N"DUXJ#2-]38TA=H_&'<\S3#]=_+<>GS33M7!ZX0@ZMAT MT^J^=;J7.OU-))D\_HQO-EM6/C.RO:D(Z%S5=:=-7>]641 ,=#DS>2BUJ"GV M L>"TR1*LH2M?Y47JR+!MK+91*ZP@ UJ)MJ*(( ;9DT'(1(*[V@<">( I+( MZLBG*:JEDL3MPX-U%- E=H5&OV&-"*P, I5>>R8R,F MAJ!1 MXUX[@!9+*E7$R.E]D/'-DXR$A>6KA*&691@6BT$:;NGWA_BC)F!YBM\>O1AD#3, M9 NJ(DROUU@%'A;U]',SOGC-XS="Z2^,O[(%P2EG)"[NP-B>.W7KW;Z7TV.[ M^6H.( X"JB$.@1=T5-#X244A'5;>/_/(TS=.MRS#(I__+FRM%*!SRP]@L\F- M(0J(%[LS@)-*C JUS^GDQ>H7U1"L^"(36$Q([GAR>:=I8XZY51L0.9T&H1GG MY9HEAY%S$>5U$FA&U)X= B6&I*[GO;99=J<[VG3!@12IT%PAF<5 MHQ:\P9HLSPO?B)DI@DC*=PU&2JW1%@M-HEH2 (BPN8+("*7(JWU2,3EAHBU[/9^%OPU>RQ7 MI05+"*C=$M)IN4F*51H0,5W^ ')T""IB]$+"/A':'196+]:3A,MKD3J&!S1K MD-/2A80-9*[%#"61NC]SPS.TY.AK2E#V2-!E^?F^^HKX13Y^O\$216J"1C%R M9S$6-I"ZQ,Z_QP(:;GV5I:4, J=>>_ 76JH(I$.\L',K>1;U*[[ M17^(*XZ&FMF#8&J@29.L/*QY&9X'(A7I?V6F^E+_\ "P(7(\;K88-(;- M-440I("VH$%S_J3@,V9/8ON<1?L[P2-"U!M=:=5^]=VU&QCMEIPW%:G)U*#0@&A[BU^ MPT,6J);'AUH?YO\6H'IQ7:U5QZ.GQ2.6I_%VFZ6J9Y7VX/OHG4&.'U ,*(#Q MF*(C(B !]B$'EGDD2@/_8"*8%2+]GH-EQY6.B3QY_T]>2!"S8!8DEWV61[N MJ>,J9$"LZRN\P<4Q+_AZ X- \:UNH)7^M<$KDGO\"4$L#!!0 ( "$]5%,F44=P6 < #=9 5 M;W!C:"TR,#(Q,3 R,%]P&ULS9Q-<]LV$(;OG>E_8)6S/MVDM6(W8RM6 M1A,G=BTE:7O)0"0D80P"&@"TI']?@!05?1#@^I*U#[9,+8!]GP5!+@'PXMTZ MY=$359I)<=GHMCJ-B(I8)DS,+QM?QLVK\6 T:D3:$)$0+@6]; C9>/?7K[]$ M]N?BMV8S&C+*DW[T7L;-D9C)M]%GDM)^]($*JHB1ZFWTE?#,'9%#QJF*!C)= M0364GUJ%NQ M3&$5C@TQF=[5UEEWMC]%\0O.Q&/?_9H232/+2^C^6K/+AFMWV^SJK"75O-WK M=+KM?S[=CN,%34F3"<*EVV\VS;FNMDT8)/R>H)*Z_;[?0ZKNY7 M!T9FL[0=4S/7KQI1^Z#=I:*:"I-+O;4'#HK0M;'=B29E1:Y]J&>&&6>\[2S= MJ.EZ5I;:MNS'PG+K2.D*E_%!Z]Q%0!Y)+7MSSEG3N#673^V$,LN[UW$?'(=. ML]/=4GYE#WW/F[N::J-(;,KZ.)E2GK?RW=H*7B2*J$*LN]K(NH^"!LIYUT:]%>$F4K:L8+QG<1GRF9^AAM>4B/H_NX;!,_ MD^F5]2)QG@PYF5=#/3(!4NUB8*U4@\OU/G!N^!)9!R#Y5RA384V.79 M]$#GS'GM''(78^H.AD<*3Q$@_C/,L2.H%C4.5T)DA#_0I50U^ \M@=1_QZ1> MI0T5]M\9488JOH'P/C$&(G^-B=RC$)7Z1!&AF:,$P7YJ#>3^!O7FQ*,1%?QX M03EWB1\1H!Y?90^$_PT6 0?CSI03A1"UJ'.ZI M8C*QEWT%B,"),9#].29[C\(70/U&)%#F.U-PUH2/_$@>*O ATS'AA5]#>TR' MH5>80\&CY*NU,E\ _'\I46#T>\90\"@I;(U$%.R#3*D#EX+CC-\:"AXE>:T3 MB4+^1AAF-FY.X7.63G\\F#TD?FH%)8V2L/I$(1(NGU@(XR9,0I2/+:&D4?+4 MD#A$V@.K2A$^$@E=?Z2;$.X34RAOE/PT* \1^+UB*5&;,8OKAY%36RARE*PT M+!"1^82L1XG5QF:LF(2L1^\M HT 2DH*DHL8B)&(I5K*O_!X>/ MDL/6RGQ1\,^>!_\,#A\ECZV5B0]_8#_>J8E<>>:_O<90\"AY;(U$?.SY=>A. MW2OYQ(KU6G7L3TI X"8WH;%XD=A>R, Z?FE)90Z8JI;+0Z?]KW4AO#_V++N MGK/:'DH>,>D-"<5Y:%GT ??PP[? Z<@$2ADESZV4@P/615M1XN_*AQ90K"C) M:Y48%*JWTLVS+*0(/ND]M8+21;V3JB[V(M 8X$X=UDC%S$07R7/ M+"N5+UY5GO/!8PH%CSAGZ9&'N5*T6)2]NS(5+S()5@.)'G+P,BT5=06>H M\YP]T??$D*V?H2CX2D"C@#B1&1:+O M #>QE:2[#\_9'AE#FB,MW*Z4AHAZG MA//K3#-!=7"T.3*$HD9%)''L%G845WN1$.5A'[*'TD?=2.H7 MBL+_SBRHVK_3RET:V9POM/RBOA0T%BBI+E0TYI5W[[T&P0OO@1V4.F)26R4, MO- 9U2Y!1,3NC;7MKG'\(T3H#@T2JAO7P)CJ C61?M$UZT]X-X M7'SC?KFWW-HC_P-02P,$% @ (3U44YZOIR!($P 8VX !( !T;3(Q M,S U-S)D,5\X:RYH=&WM/6UWVCK2WWM._X.6?>YN[>WMR58TLQH-)HWC9R3_XP&.GHA MS*:F\2DAIZ0$(H9J:M3H?4JX3C=92/RG_/'#2=^!?M#7L#\E^HYCE=+IX7"8 M&F93)NNEY6*QF![Q/@FO4VD4V2\C27+ZZ\UU6^V3 4Y2PW:PH9+)()T:S_'P M>>NDJ\)T.M.5/PF09-,+H*%5FPX(=SY,>XTS79W(KGFOJQ-TI;:9R\A'R^CP M>DP&C.+ZRIQFF"'Y>M:ZGG9WHOM/NZ8=A@V[:[(!=F -.:1\4LHD,X/H.?B-$<-L MYBRB@8<171O-RN=)7X6:MLJHE5+- >\KR] _(;8>P1I\(O[?B4,=G91/TMXG MM Z(@Q&'D23?7?KR*5$Q#8<83K(SMF M5._;IX1#1D[:VZ%I/B[M@SWY1S*) MSBG1M1)J$^<8W>(!*:&1-CI&]:KXX5'*%!_OVG]DJA>GITWXX%-!R>2ZH[.9 M1S[5Q_ 4'X,I;@ GEYV,>LWPO/1(0/: ?OB_9@ 'QQ5@#<-ZW=#(Z(J,'R70 M3Y*<.\H6-X%;#,$]'1!#@[_.N8Y[CUVLVV0#4(=GP.?JH_SHJPT/)CS:!$;F ML=W'C-B/F4>A)3T@MGBV"9PJIZ7IP\HND!0+7#&U,;*=L4X^);H@?B4D2Y:# M.G0 76[)$+7, 38.O <'0 "C72'H>)QFG4MG0\+B'#-(AHI*,2EUC"^%80 MWZBF$4-L#/X5.MZZ X"E>C(_P>BKV4P+4D91G"*0%,2 M!B:@'I-A0RYPT2DB:?%5,QS$'\"11_M<_Y4/I^"1ME;< ; (F9)5:KDZ23=P3QC-L&%9 M.T9#JCE];G*D/Q(S(Q63 1^\D6I4.T9^8P#':Y>G[=R.)6WZ M ZPD/)TR@'/4_S=$?7J&_!WRVS>OA57F-8 )P* KH%BD IBEE.]NZYU:%;4[ MIYU:^R2ME'>/LEVKW+7JG7JMC4YOJZCVM?+Y]/:BABJ-FYMZNUUOW"ZE8Z5G M$85XCN.6L\ASOL@GMH6-,+Y KQ6I7Q_VOY)Q'[N.N='.V(GDO\6*^1QZ<\1OM4'/P7GT<0GAY&:3>^M% M*2>"D&2R:JHN]QQY^/>H3N*E:>3TH]X?7]XHW_O9;WV ^;.NV6SO_$K[9@W4Z^T;L#&MVFT'M6K-1JMSHC 1U31=9KO8<)!C M CB5Y[T\@N0L,AF2\WO:OD^A/\+L(J=/>&>748<"8;61VL<&K-FIZB!HEHO9 MW/M9K)TS\F>GMAX6'A5Q9C)BF\%W@L'C);:#R MT]IN)ME]"\^JP,*<. MFR*DJGD!5[1>_/;4.3//'EBEJKU:+X:#>PTP#6!<7\/C,5!.C"B].4-8HMQ0 M'5.!,#H'= 30<]9#,57-U!1LY*^:.,)C\6GN&Q),FI M)ZN70%B'/<(S2[^"#._(69L/'M:![*G8.556]%69EZ1LD1ZU^5F-PY.VT9KL MJEK/'5D=EJ6%+7AX47A!434[$)M]_% Y;=70Y]KI=>?S@@C>V(\]J/4[O";IX MD-& >(*A2P@G;(V*$(1KC9DY[/\JWIZ#%9T !%T'5JFB1 06B'^WL*8%WS0^T._&E[K M%Z2PC73-/$Y^8 ;=Y&(QNX[-=K18'N=SOQ*/"S,\[N!1W3\%5,666L;PPI?; MQK/*"M6;[-88'D, <#^?E'*%XN%A;DWVPS_L-3OA9U?&BC+[DF>]UUZEO8HY M&%";%YLA+H/(8\-$P44+V+L)U5Z]U?:HJ0TLW1R#HIY=171KIO;C5B@MU.5O MI/MU? M%7)?OMT_;4US1"!/E+.2)*%K_$QLJA%492G4=BGX$_#\-D:/'/@IV7^:%X]U7,/]:W/A+\0CJ-$%TT+L_0W%8!7NX!"CO >,19RS<5:+EY%,[=;? M-,[=B]L'7/N<,H+C)?^I-?H3/T@M>2O.81@?:'4Y$R/I^PMZ3O(IOC9!N)M] MTU@:0U2D?.:ZJO;DFZ,M4#V/,U$NYJ!/+K<\A-CYJDY3;?^V48?HQ.(T^C[F M 8^I=9<[/(BS/+P+WC^R_IUO^Y_)MSVY-@00XT2YTB>P,/PX&5L6,RU&>4I( M,4=((;HY1%2<-7_\,*WY*"2O4)?J7(2IC2BO[->(QD^O;3IP=0<;Q'1M?8QL MB$[L[E@ ]P>8"J#'07Z)-[!I9MH%. QA8QRT=<%_-X=\',^T41ZPV:6M,61) MC!*.2>9CEE40>D@8?7KN$'IW:T+;B0CNROE]_R+[6MG'+'E;!'4N0M M?.$XUDZ$_)%H?V?">!\^T!Q&@*Q020?77)Z@Y3)Y3\8_?I@KW^!5&WOR$:J< MMU F*Z6@Y[[O=0F/:":*_RVFKQ33(!O7!@ND N.-W@WH.E!X>K2,JCGC^EFY MRN>^[E1&%\G9HH!.@<.*>M!CI%/.X:2<"0OH3%'11#QS4LKK^EM"MRZAA[Z$ M-AGA*HO?<1%5C=S",HC*XCQKTLM6CD;*66_XO%-1C:=KBR(+2))J",MZRE7. M:PD7(PEY;=]1%XX-+X^WDL9Q0A1M&JOU&\^?Q7ZH0\ZSF_JBXG(BL>*R!OS.[@Y,G? I[D MQY1T9'6ITFVV+YW,%G@]@Y 79E8^_U5YF)\3V<#:QI>ZY@Z?&V#7'YZ^O3ZS M/5]AQC7!8G%9%$T)4"&VAK^C"]U4(+YK$QU,([K![)DX&Q9T;--5B+'L;^,_ MU V->U<$*6.DBAPGC'H&;4I$J=MLZO'C!VHCD %80PZYAWK,'#I][J59/!^) M;:21+C6\BME01D?*H\7+.-,[.%FTQSL>'8ND3M 9<,'B6;S@EM?>A?R]C)+, MK'N]9P*:NWU\X +PU*YY_,HM5_.Y_/'#')M7UCTOA!P;QB6S%14!'1>"BHI' M1/0&__/N^[C6&+&+T59*2&-#DB6$K1N-;+>N_:VVZRM%J0Z^?OR^/8#=&JD% MZ,+90Q^VN%";L,4-4\07KDU$+R#7/^'@[Z:BXO#">S?&QP^PI@*9/N;8AQ1P M2%VC 0- [FCM*1,XD&]8["%]9\!N16XS-.LHB(ZF4ZPX9H$Q* MRDQC6_Y7*;>([>J.*%9J6(3YR3+0F\#W0*563-#QO"$U&QEOL_*5IT+?Y>;C M!H@;!IJ_MGL 7!/FJ@(1+?I,L.[T105*"E&>[-00!N/#J\$8V#YL$VY,#3!0 MJCC<=[AI(CKE+P)BXY 58_ZR<.O'+:339X0@<$%9GY@4 M.@53:4T.]V<0\TJ"KLL,:O=A,+>C/(<'#WG9 >(5!WOBZ[_^6+T MG)@EH#@5/.[6!._Y<@Y,VT$:9>"VZ&// 6-":\6!H#9(FVZ;$_=G>^'*CEA/ MC1/)\W41B \X03PQAMG,B:O>QK@MO4R&P..#$:H& M=ZE.-%^^Q38#U] R;2)4H>\:(KD0$7Q&A8H'?#?@@=B9'S_L\1$^GG#O8#L= M<-?5Y!(R!.\5V:[RQ-,)0# ?")*B@+@(7 ([!K/N$70 8$?Q-V>K/GE05X%4'PX'9Z(('/^,.2 )U"))6ZYDI'8*[P0B3B"< M W+;N_RJ3JD ^CY^L%VU[Y.Q0T'\7S#DQ90DI^8M^=1>BS)T?@;F&7)?2=M; MMMXSRR#^E2?GFQ 4$@XG*NJK8T_8GL]IVV!R0GL^FBG^?6S9S\8(R'R_X MQ'O'U)P;P4<^=$HC<^)B[M0LN8P0. FW9FKE'<,Y.N(/B'8QOT)A<7ZON0' M7VPC' $K*,.<"FO\388UF!%9G;"('B/OO:_A]W*04;&8E%-]9["*>N[+36C$ MZZY3G"0N6[3WF5]3N' [M9J:6$RE)NL[T2O081>'>Q M*$NGPGT[U01((E> NLP9MLC9KZ*H-RN__MLF>&!V^VXLJ;W7'J5V_N#WMW+5J;;2+ZS>!.P26<@>N M7#22\.OZO$.$[RZ$O9Y'NQ"/S2;JIP$9[]6:/7[07!XX8Y>?& CUX[]W#O! M*&4#:Z&!AYZ 1R$0975Y.,,!B;#)[\!C2]> ,0(<=IV^R6 /;C&Z7HOWO[8G M.OMR@FB+ \"X(O^4R$SHG(T>O)K)-=RMN"3<9OY6<,566N%L^OT.U^N6R\WV M6^?VZASWEL^?OU"PM.#!1-=_+(=T-BY%7TP.?K)B+)GG;TNIH_SLBLQP+3-CL"O3/DRY* MNEY'>Z5/23=TAN!=>&8K7+[EXRHY__&A7&[7OZ?NS']_< M:L-N_J@\CR\N=6F@'U'85H7[7/'+V3-KZI>65?ER:;3MR\)E_NK%L!I,^7;G MWM\V3M76G3JH?L]KI^+3W;/Q4"E>MKJ.95S=90\KNL0JAIM] M_C/[8WC7:A^VQU\JE_?5IISMD$$Q=X[OJ\JW$1VFS9=BHVGGI78S]\ECQW\! M4$L#!!0 ( "$]5%/J=Q$V#QH #<; 8 =&TR,3,P-3HL*"B)-I"@M%&DB1N!';R(BAHX(! D) M18)21$! 04"E*[WWT!$!D=X$0B(@/0$, 4+RQ??>^WU_?/>/]][GS%[KK#4S M9\TSS]ZS]QSJ#!4#X+IM:&((H*.C ]RG/0#J/$ ?0$]'][?])QB8&/[B#",C M Q/P#!#XUYA9V%B8F5F9@4!6#E96-G8:@"QG.3G8S_Y]__N1O]/_SJ(U=F8@ M,_O_&-0. #\_N!)% LKOX"@D/"ERU+25V245535;MQ4U[]E8&AD;'+;\A\K:QM; M.WNWA^Z//!Y#/0.?!@6'P$*?13^/0<6^>!F7DOHF+3WC[;O,3WGY!85%Q26? MJVMJZ^H;&IN:N[I[>OOZOPY\&QN?F)R:GIF=6\;B?JVLKOU>WR#L[1_\(1Z2 MCH[_\J(#,-#]%_Y;7MPT7O0T#1B!?WG1T8?\'<#-R'3AVAD>77.@:\"YBTJ1 MS+QZR1^K.EDDKEO@^1X\&67EEU1>OD3X2^U?S/X]8E'_*V;_E]C_XS4'8&>@ MHXG'P T T[)G^*D ?^_'4E16#]2 4S.>#3Y7&S'O7E)15(L5K6-P23O,>(1 MC^0*8O*)[K<.02[ 4;Z[3&.WDD]L]T2%N45^^:QY?.K*J[4IM8;*]?HG/QU- M1?GQ%U+L'MXO$8Y,ZI$@S?>," F,JJ8!:HVTIOQ)[+S171:FRC[5JE--5HR@- M-LB5YOX]^4/+I;"J\YCW-G&/J0#!H--K[5[C02"+U&)OBA;2_M"].ZWDR[?; M5 !X#^R#'XR%!5D'D=+?;&P/"I+9OEM[0D:A"QKKQSC,$NG&U7Y[W^I$K L3 M3-]B?'^_OU"E]TU'F&;*'3!A[I3I-!GL77$&,0?B%''"9P]]4&U5&=R<(@)L/(^\8:_0$X_DF=NYTZ^4,'!.W.9W6-P!9+:;F$M0 MVUHGJ$\[X*=:D)],5>7*%^?NA/ZH$K(6$Z3%A)$5WPJV,K#HMF6"0X#9?%LS M?&2VL;M+7O"[HO;\^;B/-ENU*P,*5PP6%TLNYQS.4-X\KHA NH-),HLET'*C M?/C=9(7:$]0_2;91"V[ID\V(/UQ,#P_O"09V>R2U8[+E/YA(!*7#; LGSFAL _AWC(WG56CA+G?;Y?7: MU\P=P9U'^I0?*3:B3\6/&+9(E[ES9 (V!X^_Y!B&]BA7WY&L^B,Q-#78VJR@ MH#9SA.M$,NW"]:S*"TT%DWQ:EO8PG-];YOUFKP7!TF3K3-.;4I]#:HZR1@KI M@$?3-B?J9#":-$PX=P=/?+]DUK?[%DSVU2K&6]V<+T32OPF2":T!1 M")Z%C09UI]KK7IG>UPQ]I8YVZ@=;A5BV1-P @PH7.9QZ2%?Y."R9_)JZJQS M_R]1+:S-2U'=S"79OE(YP;90J)ZY2>AMI2>_V];MMT$C5$ 2A1W6C9$O8)_; MB2U9K_PZ[]J8.6>\W+@;,917#],DF,LWK2JRSB[\.$M).U6GS"!K7&+07I#9 MD9Y%( &9=C:Y9*XF?FI.Q/0=W>.=Y"2Z/->6U"@&ADX5\BCY',DK )OTTIS^ MUK%U':=L%D^GQ6S[RR^ECY]?6F!G" X81C51 MYXW6T"#<[BQGU][BU[&?T"ZG&RU!#^,,;:D :2(GB0.A SW4(+A4@RH5(L#+ MCH@!!&?5 XX>XG!8 &4HU7B,5WNS\<*A/5G@N>)BOVKFW>GH\?:JJ46;I0+R MB.4Z?7&WY$V!S29)3>0NZEI77H-Z]9_V MI>LK-]!2Z:[1OUX10C1-*2S1*O4O"TC1COZHG="Q7M$_MZS.=H2;EB-_\OU! MO#RQV:0":M;Z-)"\O^-]8!G/ BJ;:QH7?OT\_Z3[QGD48Q2GKY&> >(9HF>) MY^R[_(VY!U\92]07/J]E6-_+3RJ[85W8=Y"!1*1Y+Y#\A13:&VZS)I*TZ M>/E8\-3 O(/X]@G-M3O-$1<0/VAGO4HNO>[R#4V50A(*7+TA,"7 XVBJT@36 MO#VOHX-;\8ZZG2[JH;+GU^T7&U)IK^M6L"[@;.]?PLL1N7,7K.2U2!83:Z_Q M3)W[6FT8SBD3SKSM_'(Y7+%\CJ(R K\_I*A<$-F[G%)R9KPEH,;>2\1O'SS3 M+C2LQ-XBF^@LD@>9M7+\YI^:DNEE6!#JI.);KPCV0,X.GH L&B;KED4SN+GP M=DGO'KB.OC^0#&:(W/ Z6")"0D4P92CR]KD[$E1 R)#?9N;15[F- M#Y5%EZ(_E"(N$1E6(]Y]=,!W:!,%OPJ,)%]QS9\7&[7MD?AIR)93VO\S!8)S MN8G)^U[S7;J'H*I.Z5->D&ZQ5WN3)V];/FK>VC#YI08/%FR,W0Q B9=66+[3 M0,J8G$ZC1RPMXJ0K-G!XG?\^@?Z7]>$A/5J<6(/$E>^17VP]B M2H\#',WC_,@\TYB&/M"VDR&(X;&X*,'JM/4E?UV!_6F*K;MK3WDRG\E=_[OX MP,TP9BVM(U?F/RWRXTK(NP:"5R0 MG42C("C?GQ8#3?/AO_C%OJ1SWU=(Q^]Z O/^7E0( M_*?"S!PH6AG)?GNW<-W>-V?/?]O'.YG_.(U!I".&KY\V>6-Y?H*NW>O+XHX\F@U\+P_A MFYEZ'L-KKL/TU_CZR)JG'S0O$"P[[=$O#K0>72T[I]/6-E['UG0A94'.HR;X MU8K#D-4-0T.FB+F U\:K6=B1.5!G#BN)+X"@=.)<1P4\YY^_X^1:%_8PK-AY M](WZ4-2E1T$RNB*Z7Y7IYLSO09L3U-NSF19:CM(/S4M'M9E_EM(!@3FHHO]P ME=8P8O)I+5GK1!W6HH>O'-6TPB%%2>E"\D]W.6"/>GW_L,CA+CBOFNV*WNLH MU=M-GCCW^GITDFM%%!KS;B[G"W:)=(5SVRHCIPQH-:"G MYU \?^A>_&+".U(DM1)Z&,7WG9%SEA[*B &#L6/]^_-:N=Y?")]^B[] MJL0WEO-2*=Y4]APCY9+-SYM'_BRBV4MD/J.NN?XDLL,R)Q#&B0WIX12 2=DV MC?X)5] ?VUXH'9(5V.8QE5SGT9?PLSV\D3QD 8]@G_(@\PY8CV /MVK""PG8 M8HJY;JF-::>X\K0@DY-K% M$?HTE^0NUBN6[-8*O$D*]GMV/QC-@<;D:0N3ZO"'O?8Y,1CT2QN$-%YKBU_X M,,K!T!AN4CB@=ES_6#+-[5KUSOW-"Q:?9Z0$*P2I@"A#Q ]+4M$=0C_J$BF( M( &)MB/%8+..5,+:M)D/YND/:XQ]"I,]Y&LJ?LH4ZR 8N(=#;A/LD)V^FFU2 MC\.6HLL47EC+\[U3>>J@E@K:&X=FVVANC=R_:D1AL:(")+.P?J=I?OS(]>_V M ,@,! ON!$4M53J-Q+=RB)=AEF+LY5;+0I_,_>E)A7CC%TS%NE,>IKU0,ISG MO2:7A@L,M,=16 N*?E,X700W068< MMC4:WB)V)5E)&89-31D4%@F\E&GC A7 C&@C;&B!>S]0 27AGN MQH$Y2@)3:*=6 S?78MB3XWG+5W-F\E[0BRVO_#73GY>-K MR+O:NGI(8B\M/'=RX/WX!FFTAU6B572Z' M"W&G*W@9ZOJZJ2)56W ]$:= NC2R9>=>UC<]I4#(-8U:U"A86K,U*O:,]Q04 M__)+5H>AT]%FQ@5O&_:TB::;.]S-CMO),.H[ SNFM*H2' F@\-(=E,&D^CE) MT@JH=EZRFQ]J#H@BNQ'4L,JJ\/_+*986FW)3=A9Z[+I[_1DAE#TGFR9GZ?MB/K%TL@[]62RPBM97: M;:2T:T_(?MR;ZE)Z=G251=O%[QUA\;5XT8D68E&H9*QKK$YJCC MA]].U($X2)^G-$Q[JJ5 7HG)BU?*#OV=1#$X?R&AY:<0DHPRB%N9I=44 XD& M"<'#,<;.5A >J+K/^^##31&^4#G7G%6-ES_X7-,2'D8!+K?EXJ@ \GEQ=CPP M'NZ.,U,S#=,2Z0[Q^K*8914V6O!B8?7Y#7'?/CI\7*A;O\J^44>V S&%5(3' M=4\A.5M!^'$BC 3Q*M+G?Z$RKO9"Y528G-83E^X$"/CG&P<20BY\ZW6XV5O%HVK?Q;4CXJ61ZC?/K&]SN[M MV[@&[D#BS<'LI(T1.P(='IUX $'9:V=H5U !+#ME;GSE,>&,M]PQ0X58 W\3 MPST=?_25FX[DZS@[@WZR\#Z67R!@*3HHV&#H,;<\&%N)S/['GVX#@'G4GD+3 MN)_TS$>"PK*[O TT"1-3Z%[K610>5^%O:E"RM5^G KQB@+G"U3N1COI-^O(Z M?8:/&0JS**PMA3,D8UC7/F:D7P.,ZKOF#[=1B/UXHAS MD=K93[ 97^0B!+_#[;)"FU?CP_Q*H,+#I3;U:OZJO\L_).OGQX6A+)B/IT=" MD$!:27URJFYZLUT&+I0^]7A(28\*.+N3X/O\?HG+MBR7D6 Y+>X&\3SW#!Y<##O2U"9**\LWI?$RBU:J[T/A>$$\X&T2P+>(C?A MF52' NE*[%86MH)KX&FS;S84>["W[;.XNKH!]99;1C$_T+$W<4^_E<@;Y$'? M%MV)Q%N8B>]C^V-IH8B,1?)0>!=(8YA94O!^KWIX:[!]W7>E^BY;J3=&&IPM MHEDA3QG?L^XOS7OHUA(XR7PC1-4X(O..1!188.&B<1.][<%O9]7C+Y\K#V1D M1LC\V?1P29)*0.2:/?P!?JBR_69BZZRA[I8_9.T.I\]I(=(;S8$8RBR*/7#( M5NO)D25DQ N;?R*Y=:?K[?\SP7]>V$ZOYJ(1#SV;B<3G),MHQ[5.6I%N&$GS MV80I\%E-JV60*%R.L%KE)[>86@#[]$W2R5D,($YEY M-&Z!W^WU$T9V>FK+(;NN8G-98&Z68W#.O$(4Y>*/2Y.M"S+ZS;BM3OG[,VAO MCK9V[^R\A,"?Y(#3%(0BV9(0TJWE@)7J@\3P*Y(D^M01#840CV66IYL#.]QX M'XE,TT/!;+8+.D4AHJ+F'\3;"'G$U4I2(.&97^RB -XHL5V*--7U3<[(5+7JUD_'&"G __91-B:FXY'9Y_SMM6B[I>J= M-)P9&X45A\UR>:&MC#],(/^#9O'.6:]UDCA1G3;E^')GT)-K0**=3E[+HA3R1((*.]3D4-A=O@L_]CS@/-VOAWY+Y MNE+8SGK-MD).W& N$+Q?=- "MZ^FF2MN\&'[V*4:F?A AB,'XZ7HMM9?;.)J M_!HPE7&R,CX].Q\QDGDFAND]2_X\#+'8*Z?'*:TG-TGOL][@)UB1@\:D:-.- M4B[2;D+R[6R)OEUB.G._QXW.#63_1F$?/F17#%:**&WJIHMB+O@ LH2I]0;G M:.!1:67K*W/==C6HXYGF;3?>8C$E#5%%;%P;%,J?"^7E,A!5U(NZ@4O4R_<\ M0Q]Q W!VPH+^-AX])T"4 ?-J7X7F"U1Z!LM= M>#/O-#=4<%GW@GR1S+E&=:6GH,J)XE)A,&[I"S"=>SE!H)EWQQ3 M*?$9FZ-M9R$4 3*9D!WQ@3)W9-X2$38*>= :$' 1F-/AZ4WIE,\U?J^3YX_\9F( .8X??!+BRIWJNY_/("-T,PB MWCZ-ET4_AGEH M"_K(U!,PHE?]<&N?D-6C7IY!,+)OQ/.W56PX7];F2C6I8Q%;(7B\$6D-'>9I MJ?D<$-T@BU=$RG91?&$U(VS@4X@$'S4,8HZI/MH)]ZWCNERS\.3LP> M'?](+&0)NF2V)82P=A5NH7_R,_.X.0Y H.U8;E4&BAR 0<8XBXQ+IG8_ W5! MN->?49*ACR*3T[O47EUU:\F.<4D_^1DVK7OR#QQ0>UI"!7CD\L.UT.BFL5*R MS8,II87Y#Z'W&:.;]/TA8IL_I#^PSAGF*"=>GAJU;9[7>XW2LI5F !? #PE& M1/JF7-Q.%<%TV:-'RVL9D@BW9%1=O*!Z'-Y>4K YR+K]O M3P=Z_)Z39EC-I:?MAV/U$S;/D(?J78\_CY-5LCCP)C MYC!3C<< TZ>7XOE%WC=H--WL&T-BLL4U,CJMV\],(Q^/O+"OZ#8U#:H2-JA_ MY^I:XF3W>)3A+9^&RW3FD"1^ &*!NF"!X&M MA[C$WFJC-)R_SNGQ>*WKUP8]Y5:4N?# 1>6(B.H:'V!T#F0,)(A@A87@EKHX M/#K:KU8ZV71GGB97M34\DG$ZJ]@9*[.AX^[ZU9WQ:7DU[7)[5V%& KM0$1/[ M?/FTF(P$14TI5,MZZ([?;:Z?F5])A#PZG8?M:[91_NQ2 ?3MS"0_HA_)X ,) MU*7*8(;?C96+*7LO$E^O9)?]=N_[SM!6_Y=K6IMEGR(TB[!%6T5%9,O3$@0? MW*)QTD\NB#/&W)-@;V6'4(40RT+G" KVE8[$>HD+/5KBQ/Z M8UMMRL@W26G+QI=JQN%&!0;L*]ONYP>@@7Y*M2%<_'11BDRV#[F_AX)9:;*! MZRKXX/9X6N&K2+8E 'N]T(P+B4;=QR9CVT]]A/L(NBS!Q!_TC[*5;FLTS:9& MNIB.ZH"425E$%H("2EL!UM#KPH*0WW1A^T0XQ6X@+HQEZ%=/R>[XU3-Z-1IT M#/$T%R]%?>NAMXFT0M!.^$[%VHI(*D#\8.1EC@@I$O>0D-C#X84].34HVYWO M&U7^C!F1>?SP#!]\QUQ,WP^D3C40H[7(26N%!YX9^A[0J3 M=8D6.R96;BG@;:'\=-MI45=X%]UFQW H)/+O'U+UJ=23R[ ,S-)+;4524J\V M]P19,T=P-"]<_/MH[56#KQ;L;D_WF&:R\F^P1C.D0"8/[C&)@?3,0-W6S9XM MFL'U ]ZBKVQE8D;6'<%;J2?J=H@!<$UN#$)T?2YQJLQ]V<&Z+FYGA>_2>R'Q M.Y7.0'DC\;3?$_?H#'CO :FS_P=02P,$% @ (3U44_=U4VSS$0 /60 M !8 !T;3(Q,S U-S)D,5]E>#DY+3$N:'1M[5UM<]I($O[N*O^'.=]N*JD" MS$OLV([C.@QD0QW&7L"7VD]7@S3 K(7$:B03]M??TS,C$"!V[=ADR:U3E=A( M,ST]_?IT:T3./_6N6A?[>^>?&M4Z?C+Z<]YK]EJ-B_-#\Q-W#^WM\\OK^B^L MV_NEU?AP, C\Z(R5BI.(]>18*-864]8)QMS/F0LYUA6A'!Q@(J;>)//&/!Q* M_XP5#RY>^7TU>7]^>+,RY*&DW[,Y,0PMOF>1^!+EN2>'N!3*X2@ZN#B_O&A\ M&%'(MSRKE86:5[]Q+J=VH>#:%PN58I'[\INZ;_B MR^EIOB3'PV*Q5/AU,CQ@U5;OP\'!MC=^_O&ZW4M3S@_X6'JSLS^CK<T^I]8M5V^_JV76MTV4VGT6I>-=O5 MSB_L(WZT:\UJ:W^OT^C>MGI=]O&ZPWJ?&OC;[-39S[?53J_188UVO5%GW<9- MKW%UB<^58HZ5B^42Z.)R[5.C?ML"[95)U4Z[V?ZI"T9:K6>U^6<7Y7/:S27) MNO;OR]M..V?8;'I>(;>_=^U$05^$YEHYD6 ^SZXGD0Q\5N.A8)\$]Z)1CC5] MI\!>MZO=>O7G,W9]4_OTAKU^Y;F_Q<'[]?&O0GV#!2&+1H+9<;5@/.'^S-Y\ MD]/W?$Z37X6*KJG]/0]R$"IBTG?%1. ?/V*3,+B7K@A9,&"C8"P8]UV&=42( MV8(IB7^D/X@5L:%$>"\=D@CW_2#V'>&R*'#YC%D/DI$"1>')L?1Y.&,#_/ = MR3T6"A5[N#L(POT]8BX:R=!EO\4\Q%J,N'$AYTDDQG/!):97V&5K^F@5L;2? M7(:BF?@R$0Y$$ 60QB0(H[/M[:M7O6PU6*W1:MU4ZW6XYH>#XH'^W+VIUI+/ MGYOUWJ#K^4@'P43S<7\0C^(HF"LK\'9>IV$\KT((^EP+PECF$C) M^KQ73T9,I1N-=*H&&JA?9-PIE(^D_TE79*O&9;-7KV8H^MWQDJ+?G3XH M+'!6/OF1)E00'V!$H>!*[.]1B& O$>+_Q7IJ7(W8P NF;! &8Q9,1*A1FLJP MHZ/BDAT=E5\"QO>H\H;ODK<[I/D^]P"(L[)#N;C0-H\V0>%OI?EGJ+(N+VJ! M/Q"AH/W6N.?M>EW80Y"U=12;0A,(UA[%8$95S7*YDE0STJ?0+*E^B60HHAGB MM<]ZHSA4J(IRK(WHO5#B6UL']@6J(*&#.EBX V9 &/!5 94@BJG!E F7,*>3LTJ1\<*X8#AI M%'H%%FCFF>) *^!VIZLLTLWJ;AWN0Y2,.ZA(%?)Q?\9AIMW?"X69K7UQ0:I91]XME8^.3G1-?2\Y!.O)>Q".71FPJ>C#>*?(Y8G"N;%#=WP/;=SE=[5M;'W-8\V)Y6G(Y1)T6R4S43ML)HDZU M'\111OV]Z^$GHV,@548?A_U1&P?QYQ%]G +[+&T5RHYR160@"C&D;G YA:$$ MX9VV**YHGC$#!!G$Q7M--<(J/'0U>"$[UU8S ;O@2>WO38DZ=^+(L..,PL"7 M#GF?*PWH@_;LGM5\S[9;:NS4I'(V%ES;@@V> MBJ0QTM(P/J82K*XMM- ML)M0:F?H"B<.8=;80 L_AMK^6(=R_9A5G8@FE4Y/ MCPKLXT:.]O=L4I/DU7(@35J#'\+'5.S F]19LC&.$8Z$38IO]84GQ?T: 6SU5^%$N;F$DAN(.SH=K$XPO MS1*1PKU#RK7:9P8J9QOZ2>*B?(N%QA/S>6%&I#:[)JD!E/I(,3["%@PH80:^ M:6BD;<&Z(=$CJ):XN\O((JT)1>#)5:96$-!E,)[IZ]K*DW47&7>GE3PG]8]\ MGGV4PG//V VJ'V0E\5M,<0!D63YOCPZ'8#6#ZWXH^%W>U(-G@!>T MU331XPRBM+LTIRD9IE6RM&1*GH9@940,-42R#.?:GO&U*S&:6YP53C#]CK^4;8V0I M37E\:GBT"9A"V_X>ZE4/BU/Y"C[3D9:- U=X[T$K@YC-U:FRQ%!VQ$3GWUE" M+:F;3( E*1 ,T%03LE9^.M%XIR 5E+&$;;3+ M6MQ";:)Y=PF" %*0-T^+RR<2F\8JX);#*B)8B- OLL$$I="J7 RCXT MU_>26@=$)S$^.A02XHFFP?]H9SG0%QJG3%$YH68A9PA"[N6,55(D[ NS?Q-B M($1M??BYF RVN;54XI]0=FK_"Y"5!N-Z)9H]E4KLM&V@;+])':GY. _*=1[Q MW2_1Q88#06D+M7G G9NWC0&VZ-$Y=]G<4QE^O>,Y/PQE&V:V:Y\7E.T]2E( MUHYP81,VT<6A0FT^*9P(@KXD0WVI >=/H D.!Z*NS5)U]R$ (= MRF>QKOCZ%LQ@C$HUY,-EJ6@_3.U(IZ8"-0W2*7F!"^8)EX@F);E:]8/U=C!% MV55AD$,NQ)&S.V=S\L,4TXL>1"YZ/X><<5#ZKKU1305\&$_F,[+5>VP MNG&1K?F!/3UE2GK2+(WS@+%=['^QG]SZ9I=EF#.<&-$97(=$'LF(FH^K 2C- M 8;FTI++K2+(!5)<@I#:-M2R'N?< :SJ/H=.2GA MI- 1*$_ B_8*[C@H7?2C0YW4EGJC;"A\U/:$$NEAR(3NT(18'S,@FX6#2=TH M2MC_B]T%S0,QAL)S%+^HU,FK)[CD*X+>*)2S"1ZPI&>K+^ M86W$=/9- -'4?)U4ULR&6Z[,^!33J<-D*J6BY'2!N4(15ND()GPE\&/B,E!MIS,&&G*WHDCFS'0VW77T]G2:5:6=@M5>URZ!,JHQ8(\ $]/$V>I>@9 M5'O 2H.IKVW&YGC4Z/XP[VG+16 7A.:0F:$Z"M_(6_ THKA8'=EG(,R#4F1T MH2\A>"()ZR2C?[.,*^ HDRF<0%F$M1A+2=PC\Z8\->&S><$";5+Z,%6=GDCI M-V$8O--)%=URLN7[HCB#:5TM3I+8QSZV^%^UD-WX^E;XU0'B9\L3L*NGYRUVUH^,/MP*4T(N2$C MS]UXA>B"@]HUB:;]X>#X*XXC9[YGF8HXE@UH"QF7_I8V!L9BX2@K-#[W*Z"] M48A<=06J(\4:]!Y=8I!L>XMN/)Z#=VT?$_V5I>6( M=2 TTDJ^AGOHNY\]<_3 M-2M(8-86?MC$Z&-R8^;7/U0JA>(S2"&+Z6Q'^QN*^/B;B/A) M[OAY)".1X8-)S*#EZ#VD$KV(]#2>FVL]'OADEC,^CWD\OP4_R1A*&<;PU['X M(KIOE,NVXD>Z>YIJC/YMG*A2*+WXT*Y)[OO(/QN@>_V/GB@\AW\]IF18[HUL MP/C;P&;;63$)W^_6;>])]?4V7.9%2=]82=M.O$^LZ\O4$CNX,$]F-OO_4^D_ MVL+T/.8&<=\3CRSBGVAIS[:RM;CCTT+YSRQ.K[FU;;ZH\(DJ?%?^:U3X?2". M@XMNZCR"]*F%1T=$TB<3_C;('6;P@MQW37+?7?&[ :=U'GL2YP70/\4BWQ8J M+WC^14?;3\E/! T;(=O*P:O_7WB_]FSCV\#"C'[M"[+_;K1W^M=H;QY!=O_K MXNB]U:;]\BS\ K01RMU_G>!*W@G6'?&)#(,BKBF-\>34S);_;*H M9U^B4BH73M_2=R563IY?W;<7B:H+^F5^.AG\K\47IM%7I9T?WNZTYA]RW+;R MWGX3F3IC+?HFM^_L]&WE+SP*>TC__<>%_O] Z+\-^1]02P$"% ,4 " A M/513U?/,BT,# "2# $0 @ $ ;W!C:"TR,#(Q,3 R M,"YX&UL4$L! A0#% @ (3U44R91 M1W!8!P -UD !4 ( !I@X &]P8V@M,C R,3$P,C!?<')E M+GAM;%!+ 0(4 Q0 ( "$]5%.>KZ<@2!, &-N 2 " M 3$6 !T;3(Q,S U-S)D,5\X:RYH=&U02P$"% ,4 " A/513ZG<1-@\: M W&P & @ &I*0 =&TR,3,P-3